Division of Physiological Chemistry II, Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, Sweden.
Neuroscience Center, HiLIFE, University of Helsinki, Finland; Drug Research Program, Division of Pharmacology and Pharmacotherapy, Faculty of Pharmacy, University of Helsinki, Finland.
Prostaglandins Other Lipid Mediat. 2023 Oct;168:106760. doi: 10.1016/j.prostaglandins.2023.106760. Epub 2023 Jun 17.
Ischemic cerebral stroke is a severe medical condition that affects about 15 million people every year and is the second leading cause of death and disability globally. Ischemic stroke results in neuronal cell death and neurological impairment. Current therapies may not adequately address the deleterious metabolic changes and may increase neurological damage. Oxygen and nutrient depletion along with the tissue damage result in endoplasmic reticulum (ER) stress, including the Unfolded Protein Response (UPR), and neuroinflammation in the affected area and cause cell death in the lesion core. The spatio-temporal production of lipid mediators, either pro-inflammatory or pro-resolving, decides the course and outcome of stroke. The modulation of the UPR as well as the resolution of inflammation promotes post-stroke cellular viability and neuroprotection. However, studies about the interplay between the UPR and bioactive lipid mediators remain elusive and this review gives insights about the crosstalk between lipid mediators and the UPR in ischemic stroke. Overall, the treatment of ischemic stroke is often inadequate due to lack of effective drugs, thus, this review will provide novel therapeutical strategies that could promote the functional recovery from ischemic stroke.
缺血性脑卒中是一种严重的医学病症,每年影响约 1500 万人,是全球第二大致死和致残原因。缺血性脑卒中导致神经元细胞死亡和神经功能损伤。目前的治疗方法可能无法充分解决有害的代谢变化,并可能增加神经损伤。氧气和营养物质的消耗以及组织损伤导致内质网(ER)应激,包括未折叠蛋白反应(UPR),以及受影响区域的神经炎症,并导致病变核心中的细胞死亡。脂质介质(无论是促炎还是促修复)的时空产生决定了中风的过程和结果。UPR 的调节以及炎症的消退促进了卒中后细胞活力和神经保护。然而,关于 UPR 和生物活性脂质介质之间相互作用的研究仍然难以捉摸,本综述提供了关于缺血性卒中中外源凝集素和 UPR 之间串扰的见解。总体而言,由于缺乏有效的药物,缺血性脑卒中的治疗往往效果不佳,因此,本综述将提供新的治疗策略,以促进从缺血性脑卒中的功能恢复。